Latest Breaking News On - Generation antibody therapeutics market growth - Page 1 : vimarsana.com

NEW YORK, Feb. 21, 2023 /PRNewswire/ USD 1,156.8 million was produced in 2022 by the minimal residual disease testing market, which is predicted to touch USD 3,570.1 million in 2030, advancing

United statesSouth africaSaudi arabiaSouth koreaDennis riedlPrajneesh kumarAmerican cancer societyMinimal residual diseases are highNorth americanMinimal residual disease testing market shareDemand forecastResidual disease testing marketGeneration sequencingChain reactionIn situ hybridizationEnd user